Oxytocin
Endogenous Neurohypophyseal Nonapeptide
Mechanism of Action
Endogenous cyclic nonapeptide synthesized in the hypothalamic paraventricular and supraoptic nuclei, released peripherally via the posterior pituitary and centrally through oxytocinergic projections. Acts on the oxytocin receptor (OXTR), a G-protein-coupled receptor densely expressed in the amygdala, nucleus accumbens, and hypothalamus. Intranasal administration is proposed to reach the CNS via direct nose-to-brain transport along olfactory/trigeminal pathways bypassing the blood-brain barrier, though the extent and reliability of this route is actively debated.
Key Benefits
- Increased interpersonal trust and cooperative behavior in controlled trust-game paradigms
- Reduced amygdala reactivity to fear-inducing and social threat stimuli
- Anxiolytic-type effects distinct from general sedation
- Modulation of social salience and affiliative processing
Dosing Protocol
The large majority of human intranasal oxytocin research uses acute single-dose administration ~30–45 minutes prior to a task, not chronic daily dosing. Evans et al. (2013) specifically caution that direct evidence oxytocin reaches CNS oxytocin receptors via intranasal delivery in humans remains incomplete.
Ideal Candidates
Primarily a research tool used in controlled human neuroscience and behavioral-economics studies of trust, social cognition, and fear/anxiety circuitry — not a self-directed protocol with reliably reproducible individual effects.
Side Effects & Safety
Nasal irritation, mild headache, dizziness, and transient nausea with intranasal dosing. Behavioral effects are highly context- and dose-dependent, and a meaningful share of studies report inconsistent or null findings.
Regulatory Status
FDA-ApprovedFDA-approved as an injectable (Pitocin) for labor induction and postpartum hemorrhage control. Intranasal use for social/cognitive research is off-label and relies on compounded nasal formulations — not an FDA-approved product or indication for this use. Educational reference only.
Evidence & Citations
- Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005;435(7042):673-676.
- Kirsch P, Esslinger C, Chen Q, et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25(49):11489-11493.
- Evans SL, Dal Monte O, Noble P, Averbeck BB. Intranasal oxytocin effects on social cognition: a critique. Brain Res. 2013;1580:69-77.
Frequently asked
What is Oxytocin?+
Oxytocin (Endogenous Neurohypophyseal Nonapeptide) is a peptide studied for social bonding and anxiolytic. Endogenous cyclic nonapeptide synthesized in the hypothalamic paraventricular and supraoptic nuclei, released peripherally via the posterior pituitary and centrally through oxytocinergic projections. Acts on the oxytocin receptor (OXTR), a G-protein-coupled receptor densely expressed in the amygdala, nucleus accumbens, and hypothalamus. Intranasal administration is proposed to reach the CNS via direct nose-to-brain transport along olfactory/trigeminal pathways bypassing the blood-brain barrier, though the extent and reliability of this route is actively debated.
What is the dosing protocol for Oxytocin?+
Literature commonly references 12–16 IU (intranasal) (low) to 24 IU (intranasal) (maintenance) via Intranasal (spray), on a acute/single-dose in the large majority of studies; repeated-dosing trial designs (e.g., autism social-communication research) have extended over several weeks cycle. Educational reference only — a licensed Stackhaus Health provider sets any personalized protocol.
What is the regulatory status of Oxytocin?+
FDA-approved as an injectable (Pitocin) for labor induction and postpartum hemorrhage control. Intranasal use for social/cognitive research is off-label and relies on compounded nasal formulations — not an FDA-approved product or indication for this use. Educational reference only.
Where can I access Oxytocin?+
Research-grade Oxytocin is available through Stackhaus Research. For a personalized, provider-reviewed protocol, consult a licensed clinician through Stackhaus Health.